Delivery Order SPE2DB22D1017-SPE2DB25FYPEM
- Not listed
- The Defense Logistics Agency awarded a $17,619.85 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a $36,620.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections (2 ml) with an ultimate completion date of May 23, 2025. This contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no set-aside designation and will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,709.46 for Dupixent 300 mg/2 ml pen injections on August 19, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order falls under AmerisourceBergen's comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections valued at $13,322.97 under a firm fixed price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by November 28, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a firm fixed price ceiling value of $30,051.63 and an ultimate completion date of November 18, 2025. This non-set-aside, competitively awarded contract represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a $15,755.68 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections. This is a firm fixed price, competitively awarded contract with a completion date of July 1, 2025, and represents a child order under a larger vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a ceiling value of $109,597.34. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and has an ultimate completion date of August 7, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $4,272.62. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 8, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $11,758.26. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 8, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions,...
- The Defense Logistics Agency awarded a $17,795.77 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on November 13, 2025, with completion expected by November 14, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory and allergic conditions,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPEMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injections with a ceiling value of $8,146.37 under a firm fixed price contract type. This is a non-set-aside competitive award with an ultimate completion date of August 27, 2025, and represents a child contract issued against a larger vehicle. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's $999.999 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables the contractor to supply a broad range of pharmaceutical products, specialty medications, brand-name and generic drugs, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. Dupixent is a biologic medication used in treating various inflammatory conditions, and this specific order fulfills federal medical supply requirements through AmerisourceBergen's established capability as a major pharmaceutical distributor serving defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 8/26/25 |